Drug intelligence / Profile preview

siSept9

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

siSept9 is a small interfering RNA (siRNA) designed to specifically silence the expression of Septin-9 (Sept9), a member of the septin family of GTP-binding proteins that act as a component of the cytoskeleton and scaffolding proteins for various cellular functions. In preclinical research, siSept9 is used to investigate the role of Septin-9 in maintaining the structural integrity of desmosomal cell-cell junctions. Studies in squamous cell carcinoma (SCC9) and breast cancer (T47D) cell lines have shown that siSept9-mediated knockdown of Septin-9 leads to the significant disruption of desmosomal junctions and the mislocalization of key desmosomal proteins, such as Desmoglein-2 (Dsg2) and Plakophilin-2 (PKP2), without affecting their total protein levels. This disruption of cellular adhesion is a critical mechanism that may contribute to enhanced cancer motility, invasion, and metastatic potential during tumor progression.

Other names
Septin-9 siRNASeptin9 siRNASeptin 9 siRNAsiRNA specific for Septin-9
02

Targets

SEPTIN9 (Septin-9)

Beyond the preview

Go deeper on siSept9.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on siSept9.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call